Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.

JJ, Feld; KV, Kowdley; E, Coakley; S, Sigal; DR, Nelson; D, Crawford; O, Weiland; H, Aguilar; J, Xiong; T, Pilot-Matias; B, DaSilva-Tillmann; L, Larsen; T, Podsadecki; B, Bernstein

doi:10.1056/nejmoa1315722

Public

Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.

Shared by NobleBlocks on Apr 10, 2014 • 12:00 AM UTC

Authors:

Feld JJ

Kowdley KV

Coakley E

Abstract

<h4>Background</h4>The interferon-free combination of the protease inhibitor ABT-450 with ritonavir (ABT-450/r) and the NS5A inhibitor ombitasvir (also known as ABT-267) plus the nonnucleoside polymerase inhibitor dasabuvir (also known as ABT-333) and ribavirin has shown efficacy against the hepatit...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!